COSMO
DEAD

Serial Number

77259296

Owner

Cosmo Pharmaceuticals SPA

Attorney

Joerg-Uwe Szipl

Filing Date

Aug 20, 2007

Add to watchlist:

No watchlists yet
View on USPTO

COSMO Trademark

Serial Number: 77259296

COSMO is a trademark filed by Cosmo Pharmaceuticals SPA on August 20, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Cosmo Pharmaceuticals SPA

Via C. Colombo 1
Lainate I-20020 , IT

Entity Type: 03

Trademark Details

Filing Date

August 20, 2007

Registration Date

Not Registered

Published for Opposition

June 10, 2008

Goods & Services

Pharmaceuticals, veterinary and nutraceutical preparations, namely, tablets, capsules, sugar-coated pills, granules, powders, foams, pellets, solutions, emulsions, creams, ointment, gels, plasters for use in gastrointestinal proctology and gastrointestinal located and related infections in gastroenterology, proctology, and anti-infective field; pharmaceuticals, veterinary, and nutraceutical preparations for treatment of motility control; suppositories; enema preparations; anti-inflammatory; anti-acids; anti-parasitic, namely, parasiticides; pharmaceutical, veterinary and nutraceutical preparation for use in treating flatulence, namely, anti-flatulence tablets, capsules, sugar-coated pills, granules, powders, foams, pellets, solutions, emulsions, creams, ointment, gels and plasters; cosmetic products for medical use, namely, creams, liquid, gel, foam, emulsion, suspension and powder dermatological pharmaceutical products for use in treating burns and as a disinfectant

Preparation of documents for business agendas in the field of pharmacy services, namely, data processing services in the field of pharmacy and medicine; compilation of business statistics related to the biostatistics field; online, mail order and telephone retail store featuring pharmacy and hospital; retail store featuring pharmacy and hospital; business management for pharmacies; advertising services to promote drug prescriptions; providing business information about pharmaceutical market share and pharmaceutical product trends, development and research projects; development of marketing strategies and concepts for pharmaceutical products, namely, tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, creams, ointments, gels, plasters for use in gastroenterology, proctocology, anti-flatulence fields; commercial administration of the licensing of goods and services of others; marketing consulting related to sales and volume data, prescription maker and numbers, general market trends, information regarding certain products and competitors, pharmaceutical, veterinary and nutraceutical preparations

Licensing intellectual property related to pharmaceutical specialties, namely, cosmetic, nutraceuticals and dietetic supplements, veterinary and nutraceutical preparations in the form of tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, ointments, gels, and plasters for use in gastroenterology, proctology, and the anti-infective field, motility control, the anti-inflammatory field, anti-acid, anti-parasitic, and anti-flatulence fields; legal licensing consultation in connection with pharmaceutical, veterinary and nutraceutical preparations, namely, tablets, capsules, sugar-coated pills, granules, powders, suppositories, enemas, foams, pellets, solutions, suspensions, emulsions, creams, ointments, gels, plasters for use in gastroenterology, proctology, anti-infective field, motility control, anti-inflammatory field, anti-acid, anti-parasitic, and anti-flatulence field

Medical research consisting of compilation and analysis of biostatistics; medical research in the form of pharmacovigilance in order to collect and process data on undesired and unexpected effects of medicines brought into the market; pharmaceutical research services related to the study, design, and development of new pharmaceutical, veterinary and nutraceutical preparations; chemical analysis; biological and bacteriological research; laboratory research in the field of medical and pharmaceutical sciences; medical and pharmaceutical research; research and development of new products intended for health; product safety testing related to blood levels of drugs up to their first administration to humans in the first phase of clinical trials; consumer product safety testing as related to preparation, organization and monitoring of different phases of clinical studies; medical research consisting of conducting epidemiological studies, clinical biochemistry and pharmacokinetic quality management in the field of clinical evaluation of drugs

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 12, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 12, 2010 ABN6
SOU EXTENSION 2 GRANTED
Dec 11, 2009 EX2G
SOU EXTENSION 2 FILED
Dec 9, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 9, 2009 EEXT
SOU EXTENSION 1 GRANTED
Jul 1, 2009 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 1, 2009 AITU
SOU EXTENSION 1 FILED
Jun 9, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2008 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 24, 2008 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 30, 2008 ETOF
PUBLISHED FOR OPPOSITION
Jun 10, 2008 PUBO
NOTICE OF PUBLICATION
May 21, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 2, 2008 PREV
ASSIGNED TO LIE
May 2, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 28, 2007 GNRN
NON-FINAL ACTION E-MAILED
Nov 28, 2007 GNRT
NON-FINAL ACTION WRITTEN
Nov 28, 2007 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2007 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Aug 24, 2007 MDSC
NEW APPLICATION ENTERED
Aug 23, 2007 NWAP